Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 13/8/2019
SIETES contiene 92794 citas

 
 
 1 a 20 de 86 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita originalTiene citas relacionadas Cita con resumen
Dayoub EJ, Seigerman M, Tuteja S, Kobayashi T, Kolansky DM, Giri J, Groeneveld PW. Trends in platelet adenosine diphosphate P2Y12 receptor inhibitor use and adherence among antiplatelet-naive patients after percutaneous coronary intervention, 2008-2016. JAMA Intern Med 2018;178:julio. [Ref.ID 102882]
2.Enlace a cita original Cita con resumen
Uyhazi KE, Miano T, Pan W, VanderBeek BL. Association of novel oral antithrombotics with the risk of intraocular bleeding. Jama Ophthalmol 2017:14 de diciembre. [Ref.ID 102190]
3.Enlace a cita originalTiene citas relacionadas Cita con resumen
Marciniak TA, Cherepanov V, Golukhova I, Hyun Kim M, Serebruany V. Drug discontinuation and follow-up rates in oral antithrombotic trials. JAMA Intern Med 2016;176:11 de enero. [Ref.ID 99961]
4. Cita con resumen
Young K. Who might benefit from long-term DAPT? Risk score may help . Journal Watch 2015:1. [Ref.ID 99636]
5.Tiene citas relacionadas
Mauri L, Yeh RW, Kereiakes DJ. Duration of dual antiplatelet therapy after drug-eluting stents. The authors reply. N Engl J Med 2015;372:1374. [Ref.ID 99009]
6.Tiene citas relacionadas
Tomoda H. Duration of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2015;372:1373. [Ref.ID 99008]
7.Tiene citas relacionadas
Pfisterer M, Kaiser C, Jeger R. Duration of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2015;372:1371-2. [Ref.ID 99007]
8.Tiene citas relacionadas
Marrs JC. Duration of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2015;372:1371-2. [Ref.ID 99006]
9.Tiene citas relacionadas
Dohan JL. Duration of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2015;372:1371. [Ref.ID 99005]
10.Tiene citas relacionadas
Sipahi L. Duration of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2015;372:1371. [Ref.ID 99004]
11.Tiene citas relacionadas Cita con resumen
Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Omiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon Di, Iancu AC, Trebacz J, Mauri L, for the Dual Antiplatelet Therapy (DAPT) Study Investigators. Antiplatelet therapy duration following bare metal or drug-eluting coronary stents. The dual antiplatelet therapy randomized clinical trial. JAMA 2015;313:1113-21. [Ref.ID 98862]
12.Tiene citas relacionadas Cita con resumen
Elmariah S, Mauri L, Doros G, Galper BZ, O'Neill KE, Steg G, Kerelakes DJ, Yeh RW. Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis. Lancet 2015;385:792-8. [Ref.ID 98826]
13.Tiene citas relacionadas
Lemesle G. Dual antiplatelet therapy and non-cardiovascular mortality. Lancet 2015;385:756-7. [Ref.ID 98825]
14.Tiene citas relacionadas
Colombo A, Chieffo A. Dual antiplatelet therapy after drug-eluting stents - How long to treat?. N Engl J Med 2014;371:2225-6. [Ref.ID 98422]
15.Tiene citas relacionadas Cita con resumen
Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand S-LT, Braunwald E, Wiviott SD, Cohen DJ, Holmes Jr DR, Krucoff MW, Hermiller J, Dauerman HL, Simon Di, Kandzari DE, Garratt KN, Lee DP, Pow TK, Ver Lee P, Rinaldi MJ, Massaro JM, for the DAPT Study Investigators. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2014;371:2155-66. [Ref.ID 98420]
16. Cita con resumen
Anónimo. Antithrombotic drugs. Med Lett Drugs Ther 2014;56:103-8. [Ref.ID 98343]
17.Tiene citas relacionadas Cita con resumen
Sibbing D, Massberg S. Dual antiplatelet treatment after stenting: is longer better?. Lancet 2014;384:1553-5. [Ref.ID 98305]
18.Tiene citas relacionadas Cita con resumen
Collet J-P, Silvain J, Barthélémy O, Rangé G, Cayla G, Van Belle E, Cuisset T, Elhadad S, Schiele F, Lhoest N, Ohlmann P, Carrié D, Rousseau H, Aubry P, Monségu J, Sabouret P, O'Connor SA, Abtan J, Kerneis M, Saint-Etienne C, Beygui F, Vicaut E, Montalescot G, for the ARCTIC Investigators. Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial. Lancet 2014;384:1577-85. [Ref.ID 98302]
19. Cita con resumen
Bellemain-Appaix A, Kerneis M, O'Connor SA, Silvain J, Cucherat M, Beygui F, Barthélémy O, Collet J-P, Jacq L, Bernasconi F, Montalescot G, for the ACTION Study Group. Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis. BMJ 2014;349:g6269. [Ref.ID 98292]
20. Cita con resumen
del Castillo-Carnevali H, Barrios Alonso V, Zamorano Gómez JL. Antiagregación: resistencia a fármacos tradicionales y papel de los nuevos antiplaquetarios. Med Clin (Barc) 2014;143:222-9. [Ref.ID 97903]
Seleccionar todas
 
 1 a 20 de 86 siguiente >>